Membranous or Cytoplasmic HER2 Expression in Colorectal Carcinoma: Evaluation of Prognostic Value Using Both IHC & BDISH-Reference-Cited by-同舟云学术

Membranous or Cytoplasmic HER2 Expression in Colorectal Carcinoma: Evaluation of Prognostic Value Using Both IHC & BDISH

Published:2018-02-07 Issue:2 Volume:36 Page:129-140
ISSN:0735-7907
Container-title:Cancer Investigation
language:en
Short-container-title:Cancer Investigation

Author:

Buhmeida Abdelbaset¹,Assidi Mourad¹²,Al-Maghrabi Jaudah³,Dallol Ashraf¹²,Sibiany Abdulrahman⁴,Al-Ahwal Mahmoud⁵,Chaudhary Adeel¹,Abuzenadah Adel¹²,Al-Qahtani Mohammed¹

Affiliation:

1. Center of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah, Saudi Arabia

2. KACST Technology Innovation Center in Personalized Medicine, King Abdulaziz University, Jeddah, Saudi Arabia

3. Department of Pathology, Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia

4. Department of Surgery, Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia

5. Department of Internal Medicine, Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia

Funder

National Plan for Science, Technology and Innovation

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/07357907.2018.1439054

Reference71 articles.

1. Important molecular genetic markers of colorectal cancer

2. Association of colorectal cancer susceptibility variants with tumor subtypes in three large prospective cohorts.

3. DNA ploidy in colorectal cancer, heterogeneity within and between tumors and relation to survival

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Systematic literature review and meta-analysis of HER2 amplification, overexpression, and positivity in colorectal cancer;JNCI Cancer Spectrum;2023-10-10

2. Human Epidermal Growth Factor Receptor 2 (HER2) Expression in Colorectal Carcinoma: A Potential Area of Focus for Future Diagnostics;Cureus;2022-03-03

3. Prognostic value of matrix metalloproteinase 2 protein expression in ovarian cancer is age- and stage-dependent;European Journal of Gynaecological Oncology;2022

4. Beyond RAS and BRAF: HER2, a New Actionable Oncotarget in Advanced Colorectal Cancer;International Journal of Molecular Sciences;2021-06-24

5. HER2 overexpression is a putative diagnostic and prognostic biomarker for late-stage colorectal cancer in North African patients;Libyan Journal of Medicine;2021-01-01